Integral membrane protein 2 of Epstein-barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases

Immunity

Volumn 2, Issue 2, 1995, Pages 155-166

  Miller, Cheryl L ^a   Burkhardt, Anne L ^b   Lee, Jennifer H ^a   Stealey, Becky ^b   Longnecker, Richard ^c   Bolen, Joseph B ^b   Kieff, Elliott ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE; VIRUS PROTEIN;

ARTICLE; B LYMPHOCYTE; CROSS LINKING; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTIGENS, VIRAL; B-LYMPHOCYTES; CELLS, CULTURED; ENZYME ACTIVATION; HERPESVIRUS 4, HUMAN; HUMAN; PHOSPHORYLATION; PROTEIN-TYROSINE KINASE; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VIRAL MATRIX PROTEINS;

EID: 0028970289     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(95)80040-9     Document Type: Article

References (87)

1. Molecular mimicry of the antigen receptor signalling motif by transmembrane proteins of the Epstein—Barr virus and the bovine leukaemia virus
2. The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and the Epstein—Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events
3. Nonreceptor tyrosine protein kinases
4. Epstein—Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts
5. Surface immunoglobulin crosslinking activates a tyrosine kinase pathway in B cells that is independent of protein kinase C
6. Epidermal growth factor regulates p21 ras through the formation of a complex of receptor, Grb2 adaptor protein, and Sos nucleotide exchange factor
7. Immune complex kinase assays for tyrosine protein kinases
8. Anti-immunoglobulin stimulation of B lymphocytes activates srcrelated protein tyrosine kinases
9. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases
10. Temporal regulation of nontransmembrane protein tyrosine kinase enzyme activity following T cell antigen receptor engagement
11. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma
12. Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells
13. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates
14. Membrane immunoglobulin and its accomplices: new lessons from an old receptor
15. 2+ mobilization and protein kinase C translocation
16. B lymphocyte antigen receptors (mlg) are non-covalently associated with a disulfide linked, inducibly phosphorylated glycoprotein complex
17. Association between B-lymphocyte membrane immunoglobulin and multiple members of the Src family of protein tyrosine kinases
18. Stimulation of B-cells via the membrane immunoglobulin receptor or with phorbol myristate 13-acetate induces tyrosine phosphorylation and activation of a 42 kDa microtubule-associated protein 2 kinase
19. Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50 Csk
20. Human pre-B and B cell membrane μ-chains are noncovalently associated with a disulfide-linked complex containing a product of the B29 gene
21. Predominant expression and activation-induced tyrosine phosphorylation of phospholipase Cγ2 in B lymphocytes
22. Epstein—Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
23. The when and how of Src regulation
24. Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata
25. Structure and function of the B cell antigen receptor
26. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc
27. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation
28. Signal transduction by the cytoplasmic domains of FcɛRI-γ and TCR-ζ in rat basophilic leukemia cells
29. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras
30. Stimulation of protein tyrosine phosphorylation by the B-lymphocyte antigen receptor
31. Membrane immunoglobulin cross-linking regulates phosphatidylinositol 3-kinase in B lymphocytes
32. Targets of B lymphocyte antigen receptor signal transduction include the p21 ras GTPase-activating protein (GAP) and two GAP-associated proteins
33. Genetic analysis of immortalizing functions of Epstein—Barr virus in human B lymphocytes
34. B cell antigen receptor cross-linking triggers rapid protein kinase C independent activation of p21 ras1
35. Molecular components of the B-cell antigen receptor complex of the IgM class
36. B lymphocyte activation is accompanied by phosphorylation of a 72-kDa proteintyrosine kinase
37. Association of the 72-kDa protein-tyrosine kinase PTK72 with the B cell antigen receptor
38. Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice
39. Regulation of B cell antigen receptor signal transduction and phosphorylation by CD45
40. Epstein-Barr virus latent membrane protein 1 is essential for B lymphocyte growth transformation
41. The Epstein-Barr virus (EBV) BZLF1 immediate early gene product differentially affects latent versus productive EBV promoters
42. Mutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture
43. Role of the CD45 tyrosine phosphatase in signal tranduction in the immune system
44. Molecular cloning of human Syk
45. 2+ signaling and desensitization in B cells
46. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling
47. Cross-linking of surface immunoglobulin activates srcrelated tyrosine kinases in WEHI 231 cells
48. Epstein—Barr virus
49. An Epstein—Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase
50. The only domain which distinguishes Epstein—Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential
51. The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein—Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro
52. Deletion of DNA encoding the first five transmembrane domains of Epstein—Barr virus latent membrane proteins 2A and 2B
53. The Epstein—Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation
54. BHRF1, the Epstein—Barr virus gene with homology to Bcl-2, is dispensable for B-lymphocyte transformation and virus replication
55. Tyrosine phosphorylation of vav protooncogene product containing SH2 domain and transcription factor motifs
56. The IgM-associated protein mb-1 as a marker of normal and neoplastic B cells
57. An integral membrane protein (LMP2) blocks reactivation of Epstein—Barr virus from latency following surface immunoglobulin cross-linking
58. Epstein—Barr virus biology, pathogenesis, and medical aspects
59. Identification of target antigens for the human cytotoxic T cell response to Epstein—Barr virus (EBV): implication for the immune control of EBV-positive malignancies
60. Regulation of Src family tyrosine kinases in lymphocytes
61. Constitutive activation of Src family kinases in mouse embryos that lack Csk
62. Activation of phosphatidylinositol-3′ kinase by Src-family kinase SH3 binding to the p85 subunit
63. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes
64. Interaction of shc with the ζ chain of the T cell receptor upon T cell activation
65. Antigen receptor tail clues
66. An Epstein—Barr virus with a 58-kilobase-pair deletion that includes BARFOtransforms B lymphocytes in vitro
67. The spliced BZLF1 gene of Epstein—Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle
68. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases
69. Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement
70. B cell antigen receptor crosslinking induces phosphorylation of the p21 ras oncoprotein activators Shc and mSos1 as well as assembly of complexes containing Shc, Grb2, mSos1, and a 145 kDa tyrosine phosphorylated protein
71. Pathways of activation of the Epstein—Barr virus productive cycle
72. B cell antigen receptor stimulation induces formation of a Shc—Grb2 complex containing multiple tyrosine-phosphorylated proteins
73. SH2 domains recognize specific phosphopeptide sequences
74. Recombinant Epstein—Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro
75. Cross-linking of cell surface immunoglobulin induces Epstein—Barr virus in Burkitt lymphoma lines
76. Synchronous and sequential activation of latently infected Epstein—Barr genomes
77. 2+ mobilization through distinct pathways
78. Surface immunoglobulin—mediated signal transduction involves rapid phosphorylation and activation of the protooncogene product Raf-1 in Human B cells
79. Use of second site homologous recombination to demonstrate that Epstein—Barr virus nuclear protein 38 is not important for lymphocyte infection or growth transformation
80. Epstein—Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation
81. Cross-linking of surface IgM stimulates the Ras/Raf-1/MEK/MAPK cascade in human B lymphocytes
82. Activation of latent Epstein—Barr virus by antibody to human IgM
83. Diminished tyrosine protein kinase activity in T cells unresponsive to TCR stimulation
84. Signal transduction by lymphocyte antigen receptors
85. Association of B cell antigen receptor with protein tyrosine kinase Lyn
86. Activation of Src-like protein tyrosine kinase Lyn and its association with phosphatidylinositol 3-kinase upon B-cell antigen receptor mediating signalling
87. Hematopoietic cells express two forms of lyn kinase differing by 21 amino acids in the amino terminus